ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KURA Kura Oncology Inc

20.61
-0.08 (-0.39%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -0.39% 20.61 19:00:00
Open Price Low Price High Price Close Price Previous Close
20.92 20.37 21.373 20.61 20.69
more quote information »

Recent News

Date Time Source Heading
5/29/202406:30GLOBEKura Oncology to Participate in Jefferies Global Healthcare..
5/24/202415:06EDGAR2Form 8-K - Current report
5/20/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/20/202415:19EDGAR2Form 144 - Report of proposed sale of securities
5/14/202406:30GLOBEKura Oncology Completes Enrollment in Registration-Directed..
5/08/202406:30GLOBEKura Oncology to Participate in Bank of America Securities..
5/03/202406:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
5/02/202415:05GLOBEKura Oncology Reports First Quarter 2024 Financial Results
4/25/202406:30GLOBEKura Oncology to Report First Quarter 2024 Financial Results
4/22/202406:30GLOBEKura Oncology Receives Breakthrough Therapy Designation for..
4/10/202406:30GLOBEKura Oncology to Participate in Stifel Targeted Oncology..
4/05/202406:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
3/06/202406:30GLOBEKura Oncology Reports First Patient Dosed in Trial of..
3/01/202416:00GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
2/27/202415:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/27/202415:03EDGAR2Form 8-K - Current report
2/27/202415:01GLOBEKura Oncology Reports Fourth Quarter and Full Year 2023..
2/26/202406:30GLOBEKura Oncology Doses First Patient in KOMET-008 Trial of..
2/22/202406:30GLOBEKura Oncology to Participate in Three Upcoming Investor..
2/20/202406:30GLOBEKura Oncology to Report Fourth Quarter and Full Year 2023..
2/15/202415:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/14/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/14/202416:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202416:21EDGAR2Form S-3 - Registration statement under Securities Act of..
2/02/202406:30GLOBEKura Oncology Reports Inducement Grants Under Nasdaq Listing..
1/31/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/30/202415:10EDGAR2Form 144 - Report of proposed sale of securities
1/30/202406:08EDGAR2Form 8-K - Current report
1/30/202406:00GLOBEKura Oncology Reports Positive Preliminary Ziftomenib..
1/26/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/26/202415:08EDGAR2Form 8-K - Current report
1/24/202415:12EDGAR2Form 144 - Report of proposed sale of securities
1/24/202406:00GLOBEKura Oncology Announces Oversubscribed $150 Million Private..
1/04/202415:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202308:01EDGAR2Form 8-K - Current report
12/11/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202306:30GLOBEKura Oncology’s Menin Inhibitor Ziftomenib Selected for The..
11/28/202306:30GLOBEKura Oncology to Participate in the JMP Securities..
11/02/202315:39EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/02/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:03EDGAR2Form 8-K - Current report
11/02/202315:01GLOBEKura Oncology Reports Third Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock